Endo International plc Stock Price and Value Analysis

Should you buy Endo International plc stock? (NasdaqGS:ENDP). Let's see how it does in our automated value investing analysis system.

ENDP Free Cash Flow Trend

Free Cash Flow trendline for ENDP
Free Cash Flow trendline for Endo International plc

Hmm, we can't give any reliable projection for Endo International plc's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has stable growth.
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the ENDP Numbers

ENDP Price
(Endo International plc stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drug Manufacturers - Specialty & Generic stocks
[?] Cash Yield 98.74%
[?] Free Cash Flow Jitter 24%

Is Endo International plc Stock on Sale?

Based on our analysis, we believe that you should not buy Endo International plc right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ENDP Stock?

Does Endo International plc have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.